US 12318426
Compositions and methods for the treatment of metabolic and liver disorders
granted A61KA61K38/16A61K47/542
Quick answer
US patent 12318426 (Compositions and methods for the treatment of metabolic and liver disorders) held by Viking Therapeutics, Inc. expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Viking Therapeutics, Inc.
- Grant date
- Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K38/16, A61K47/542, A61P, A61P1/16